Testing effectiveness (Phase 2)Study completedNCT00108069What this trial is testingTamoxifen and Bortezomib to Treat Recurrent Brain TumorsWho this might be right forGlioma National Cancer Institute (NCI) 43
Testing effectiveness (Phase 2)Study completedNCT01006369What this trial is testingHydroxychloroquine, Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic Colorectal CancerWho this might be right forColorectal Cancer Rutgers, The State University of New Jersey 38
Large-scale testing (Phase 3)Study completedNCT00022516What this trial is testingLow-dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-negative Early Breast CancerWho this might be right forBreast Cancer ETOP IBCSG Partners Foundation 1,086
Testing effectiveness (Phase 2)Study completedNCT00271609What this trial is testingBevacizumab for Recurrent Malignant GliomaWho this might be right forRecurrent High-Grade GliomasMalignant Gliomas National Cancer Institute (NCI) 88
Early research (Phase 1)Study completedNCT00019565What this trial is testingPET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis TherapyWho this might be right forUnspecified Adult Solid Tumor, Protocol Specific National Institutes of Health Clinical Center (CC) 53
Testing effectiveness (Phase 2)WithdrawnNCT01176500What this trial is testingA Pilot, Open-label Study of 18F-Fluciclatide PET/CT Imaging in the Evaluation of Anti-angiogenic Therapy in Solid TumorsWho this might be right forColon CancerLung CancerCervical Cancer+2 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT05360979What this trial is testingA Clinical Study of Immunotherapy Combined With Chemotherapy and Anti-angiogenic Therapy in Operable NSCLCWho this might be right forNon-small Cell Lung Cancer Second Xiangya Hospital of Central South University 42
Testing effectiveness (Phase 2)Looking for participantsNCT06371586What this trial is testingNeo-Sequence 2：NCT Plus Anti-angiogenesis Therapy and Immunotherapy for LADGCWho this might be right forGastric CancerDiffuse Type Carcinoma Cancer Institute and Hospital, Chinese Academy of Medical Sciences 67
Early research (Phase 1)Study completedNCT00879554What this trial is testingA Safety And Pharmacokinetic Study With CVX-045 In Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorsNeoplasmsCarcinoma+2 more Pfizer 40
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06890871What this trial is testingRadiotherapy with Immunotherapy and Anti-Angiogenic Therapy for Advanced HER2-Negative Breast Cancer: a Single-Arm StudyWho this might be right forBreast Cancer, Metastatic Breast Cancer Zhongnan Hospital 25
Not applicableNot Yet RecruitingNCT06470178What this trial is testingA Real-World Study of Neoadjuvant/Conversion Therapy for Colorectal Cancer With Chemotherapy And Anti-Angiogenic Targeted AgentsWho this might be right forColorectal Cancer Wuhan University 70
Large-scale testing (Phase 3)Active Not RecruitingNCT04704921What this trial is testingPivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMDWho this might be right forAMDnAMDWet Age-related Macular Degeneration+6 more AbbVie 671
Testing effectiveness (Phase 2)Study completedNCT00094835What this trial is testingStudy to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)Who this might be right forLung CancerNon-Small Cell Lung Cancer Amgen 51
Testing effectiveness (Phase 2)Looking for participantsNCT07335497What this trial is testingCR-001 in Adult Participants With Locally Advanced or Metastatic Solid TumorsWho this might be right forLocally Advanced / Metastatic Solid Tumors Crescent Biopharma, Inc. 290
Large-scale testing (Phase 3)Study completedNCT01668784What this trial is testingStudy of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025)Who this might be right forAdvanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell Carcinoma Bristol-Myers Squibb 821
Testing effectiveness (Phase 2)Study completedNCT00094055What this trial is testingStudy of the Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid CancerWho this might be right forThyroid Neoplasms Pfizer 60
Testing effectiveness (Phase 2)UnknownNCT04459078What this trial is testingClinical Study of Camrelizumab Combined With APatinib and Albumin Paclitacxel in Patients With Advanced Lung AdenocarcinomaWho this might be right forAdenocarcinoma of the Lung Hunan Cancer Hospital 63
Testing effectiveness (Phase 2)UnknownNCT03461185What this trial is testingAnti-angiogenesis Combine With EGFR-TKI in Advanced Non-squamous Non Small Cell Lung CancerWho this might be right forNon Small Cell Lung Cancer Xinqiao Hospital of Chongqing 100
Not applicableStudy completedNCT04566185What this trial is testingEvaluation of the Predictive Value of 18F-fluorodeoxyglucose Positron Emission Tomography and Brain Perfusion Computed Tomography for the Efficacy of Anti-angiogenic Therapy (Bevacizumab) in Recurrent GlioblastomaWho this might be right forGlioblastoma Centre Hospitalier Universitaire de Nīmes 14
Testing effectiveness (Phase 2)Study completedNCT01497704What this trial is testingDose-Escalation and Safety Trial of YN968D1Who this might be right forCancer Patients With Solid Tumors Elevar Therapeutics 55